{"id":"https://openalex.org/W2591335006","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.14626","title":"Phase I open-labeled trial of gemcitabine and dasatinib in advanced solid tumors","display_name":"Phase I open-labeled trial of gemcitabine and dasatinib in advanced solid tumors","publication_year":2008,"publication_date":"2008-05-20","ids":{"openalex":"https://openalex.org/W2591335006","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.14626","mag":"2591335006"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2008.26.15_suppl.14626","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.14626","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.14626","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109116799","display_name":"S. Vemulapalli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Vemulapalli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Kurzrock","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066684019","display_name":"Herbert A. Fritsche","orcid":"https://orcid.org/0000-0002-3415-3238","observed_orcids":["https://orcid.org/0000-0002-3415-3238"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Fritsche","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036211173","display_name":"Jennifer J. Wheler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. J. Wheler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102972148","display_name":"Stacy Moulder","orcid":"https://orcid.org/0000-0001-8890-7077","observed_orcids":["https://orcid.org/0000-0001-8890-7077"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. L. Moulder","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032987754","display_name":"Massimo Cristofanilli","orcid":"https://orcid.org/0000-0002-4194-7175","observed_orcids":["https://orcid.org/0000-0002-4194-7175"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Cristofanilli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056155869","display_name":"M. Gonzalez-De Luna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Gonzalez-De Luna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"R. Khan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Khan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110404150","display_name":"Yongping Xu","orcid":"https://orcid.org/0009-0008-6333-8224","observed_orcids":["https://orcid.org/0009-0008-6333-8224"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5026095888","display_name":"David S. Hong","orcid":"https://orcid.org/0000-0001-8721-1609","observed_orcids":["https://orcid.org/0000-0001-8721-1609"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. S. Hong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"15_suppl","first_page":"14626","last_page":"14626"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.8817999958992004,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.8817999958992004,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.021800000220537186,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.01489999983459711,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.953000009059906},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":1.0},{"id":"https://openalex.org/keywords/src-family-kinases","display_name":"Src family kinases","score":0.8539999723434448},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8659999966621399},{"id":"https://openalex.org/keywords/gemcitabine-resistance","display_name":"gemcitabine resistance","score":0.9369999766349792},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.656000018119812},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7760000228881836},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8529999852180481},{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.9509999752044678},{"id":"https://openalex.org/keywords/inflammatory-breast-cancer","display_name":"inflammatory breast cancer","score":0.6850000023841858},{"id":"https://openalex.org/keywords/thymoma","display_name":"thymoma","score":0.949999988079071},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6050000190734863},{"id":"https://openalex.org/keywords/bcr-abl-tyrosine-kinase-inhibitors","display_name":"BCR-ABL tyrosine kinase inhibitors","score":0.640999972820282},{"id":"https://openalex.org/keywords/c-kit-inhibitors","display_name":"c-KIT inhibitors","score":0.8109999895095825},{"id":"https://openalex.org/keywords/oral-anticancer-therapy","display_name":"oral anticancer therapy","score":0.4180000126361847},{"id":"https://openalex.org/keywords/refractory-cancer","display_name":"refractory cancer","score":0.4009999930858612}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9454399943351746},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.899185061454773},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8121526837348938},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6049544811248779},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5779727697372437},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3635003864765167},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3598693013191223},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35899120569229126},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.14435285329818726},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06796208024024963}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2008.26.15_suppl.14626","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.14626","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.14626","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2039132395","https://openalex.org/W2245598244","https://openalex.org/W2525124319","https://openalex.org/W2923341767","https://openalex.org/W2562790498","https://openalex.org/W2603578455","https://openalex.org/W2761188734","https://openalex.org/W2329131347","https://openalex.org/W2090206737","https://openalex.org/W3081049380"],"abstract_inverted_index":{"14626":[0],"Background:":[1],"The":[2,99,212],"Src":[3,20,38,61],"family":[4,62],"of":[5,19,56,63,68,178,190,231,297,303],"kinases":[6,21],"plays":[7],"a":[8,51,73,102,121,250],"key":[9],"role":[10],"in":[11,40,76,125,184,229,263,331,340],"cell":[12,42],"cycle":[13,168],"control,":[14],"adhesion,motility,survival":[15],"and":[16,29,34,70,139,143,166,180,209,276,283,293,308,321,337],"angiogenesis.":[17],"Deregulation":[18],"has":[22,109,197],"been":[23,194],"shown":[24],"to":[25,31,87,97,111,127,163,199,290,324,347],"cause":[26],"malignant":[27],"transformation":[28],"contribute":[30],"tumorigenic":[32],"growth":[33],"progression.":[35],"Moreover":[36],"increased":[37],"phosphorylation":[39],"pancreatic":[41],"lines":[43],"is":[44,50,72,101,115,299,305],"associated":[45],"with":[46,82,94,120,205,249],"gemcitabine":[47,69,78,129,210],"resistance.":[48,79],"Dasatinib":[49,114],"potent":[52],"orally":[53,117],"active":[54],"inhibitor":[55],"the":[57,60,66,234],"BCR-ABL,":[58],"c-KITand":[59],"kinases.":[64],"Therefore":[65],"combination":[67],"dasatinib":[71,206,282],"rational":[74],"approach":[75],"overcoming":[77],"Methods:":[80],"Pts":[81],"advanced":[83],"solid":[84],"tumors":[85],"refractory":[86],"standard":[88],"therapy":[89],"were":[90,274],"eligible":[91],"including":[92,153],"pts":[93,192,237,241],"previous":[95],"exposure":[96],"gemcitabine.":[98],"trial":[100],"conventional":[103],"phase":[104],"I":[105],"3+3":[106],"dose-escalation":[107],"design.MTD":[108],"yet":[110,198],"be":[112,200],"reached.":[113],"administered":[116],"continuously":[118],"qd":[119],"7":[122,136],"day":[123],"run":[124],"prior":[126,162],"first":[128],"dose.":[130],"Gemcitabine":[131],"was":[132,227,261,329],"given":[133],"weekly":[134],"for":[135,147,244,255],"weeks":[137,141],"(cycle1)":[138],"3":[140,240],"on":[142,253],"1":[144],"week":[145],"off":[146],"all":[148],"other":[149],"cycles.":[150],"Correlative":[151],"studies":[152],"PKs":[154],"at":[155],"MTD,PBMCs,circulating":[156],"tumor":[157],"cells":[158],"(CTCs)":[159],"samples":[160],"pre,":[161],"starting":[164],"gemcitabine,":[165],"post":[167],"1.":[169],"PD":[170],"analysis":[171,177,296],"included":[172],"CTC":[173],"levels,":[174],"western":[175,294],"blots":[176],"total":[179,189],"phosphorylated":[181],"Src&VEGF":[182],"levels":[183,273,287,313,320],"pt\u2019s":[185],"PBMCs/serum.":[186],"Results:":[187],"A":[188],"12":[191],"have":[193],"treated.":[195],"MTD":[196],"determined.":[201],"Dose":[202],"escalation":[203,310],"continues":[204],"(100mg":[207],"qd)":[208],"(600mg/m2).":[211],"most":[213],"common":[214],"drug":[215],"related":[216],"toxicities":[217],"include":[218],"anemia":[219],"(58%),":[220,222],"leukopenia":[221],"&thrombocytopenia":[223],"(58%).":[224],"Pleural":[225],"effusion":[226],"observed":[228,330],"17%":[230],"pts.":[232],"Currently,of":[233],"5":[235],"evaluable":[236],"by":[238],"RECIST":[239],"had":[242],"SD":[243,339],"4":[245],"months":[246],"or":[247,288],"longer":[248],"thymoma":[251,341],"pt":[252,268],"study":[254],"11":[256],"months.":[257],"One":[258],"confirmed":[259],"PR":[260],"noted":[262],"an":[264],"inflammatory":[265,334],"breast":[266,335],"cancer":[267],"(54%":[269],"decrease":[270],"(RECIST).":[271],"CTCs":[272,312],"low":[275],"showed":[277,314],"no":[278,315,322],"significant":[279,316,344],"changes":[280],"after":[281],"dasatinib+gemcitabine":[284,304],"from":[285,318],"predose":[286,319],"correlation":[289,323],"response.":[291],"PK":[292],"blot":[295],"PBMCS/serum":[298],"pending.":[300],"Conclusions:":[301],"Combination":[302],"well":[306],"tolerated":[307],"dose":[309],"continues.":[311],"change":[317],"response":[325],"but":[326],"clinical":[327],"activity":[328],"triple":[332],"negative":[333],"ca":[336],"prolonged":[338],"ca.":[342],"No":[343],"financial":[345],"relationships":[346],"disclose.":[348]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-03-03T00:00:00"}